PATENT CLAIM ANALYSIS

Application Number: 15755399
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["530", "345000"]

Abstract:
The present invention is directed towards methods for treating non-alcoholic fatty liver disease (NAFLD) in a patient and determining prognosis of NAFLD in a patient.

Claim (Index 31):
The method of  claim 23 , wherein the pathway is glycogen biosynthesis, and the pathway protein is GSK3\u03b2.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.16667
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14778379', '14777001', '13157977', '15032508', '13178986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6857155041602334
- 35 USC 102 Novelty (BERT): 0.513276175162213
- Combined Prediction Score: 0.6684715712604313
- Mean Citation Score: 252.559652
- Max Citation Score: 285.673
- Similarity Product: 192.4036435456276

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test